laitimes

Popular science short video: What is the interventional treatment and ablation treatment of liver cancer?

Interventional therapy and ablation therapy play a very important role in the treatment of liver cancer, so what are these two treatments? How does it work? Professor Qin Shukui of Jinling Hospital in Nanjing gave us an answer to this doubt.

What is the interventional treatment and ablation treatment of liver cancer?

Interventional treatment for liver cancer is usually through the hepatic artery, where a catheter is inserted into the tumor's innervated vessel, from which contrast agent is injected to show the diagnosis of the tumor, and embolization of the tumor is performed with embolic agents such as gelatin sponges, microspheres, or iodine oil. Because liver cancer is a paravascular tumor, embolism can play a big role. Sometimes some chemotherapy drugs or other drugs are injected for treatment, which is the narrow sense of interventional treatment of liver cancer.

Generalized interventional therapy includes radiofrequency therapy, ablation therapy, anhydrous alcohol treatment, etc., which is a local treatment method for liver cancer, which has been proved by a large number of clinical practice experience and clinical studies at home and abroad, and is effective, which can alleviate patient symptoms, improve quality of life, and prolong survival.

Expert Profiles

Popular science short video: What is the interventional treatment and ablation treatment of liver cancer?

Professor Qin Shukui

Chief Physician and Doctoral Supervisor of Cancer Center of Nanjing Jinling Hospital

Distinguished Professor of Nanjing University of Traditional Chinese Medicine and Nanjing Medical University

Editor-in-chief of the National Journal of Clinical Oncology, a national source journal of statistics

Vice Chairman of the Chinese Society of Clinical Oncology (CSCO).

Deputy Supervisor of Beijing CSCO Foundation

Chairman of the Cancer Rehabilitation and Palliative Care Committee of the Chinese Anti-Cancer Association

Expert of the Hematology and Tumor Drug Advisory Committee of the State Food and Drug Administration

Chairman of the Expert Committee on Capacity Building and Continuing Education of the National Health Commission

Read on